EvokAI Creative Labs - Public Comps and Valuation Multiples

EvokAI Creative Labs Overview

About EvokAI Creative Labs

EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.

Founded

2011

HQ

Employees

Website

evokailabs.com

Sectors

Medical Devices
HealthTech

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$1.4M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

EvokAI Creative Labs Financials

EvokAI Creative Labs has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, EvokAI Creative Labs achieved revenue of n/a and an EBITDA of -$11.9M.

EvokAI Creative Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX

See EvokAI Creative Labs valuation multiples based on analyst estimates

EvokAI Creative Labs P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	n/a	n/a	XXX	XXX	XXX
Gross Profit	n/a	n/a	XXX	XXX	XXX
Gross Margin	NaN%	NaN%	XXX	XXX	XXX
EBITDA	-$0.5M	-$11.9M	XXX	XXX	XXX
EBITDA Margin	-Infinity%	-Infinity%	XXX	XXX	XXX
Net Profit	n/a	-$0.5M	XXX	XXX	XXX
Net Margin	NaN%	-Infinity%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

EvokAI Creative Labs Stock Performance

As of April 15, 2025, EvokAI Creative Labs's stock price is CAD 0 (or $0).

EvokAI Creative Labs has current market cap of CAD 0.9M (or $0.6M), and EV of CAD 2.0M (or $1.4M).

See EvokAI Creative Labs trading valuation data

EvokAI Creative Labs Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.4M	$0.6M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

EvokAI Creative Labs Valuation Multiples

As of April 15, 2025, EvokAI Creative Labs has market cap of $0.6M and EV of $1.4M.

EvokAI Creative Labs's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate EvokAI Creative Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for EvokAI Creative Labs and 10K+ public comps

EvokAI Creative Labs Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$1.4M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	-0.1x	XXX	XXX	XXX
P/E	-0.1x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	-0.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get EvokAI Creative Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

EvokAI Creative Labs Valuation Multiples

EvokAI Creative Labs's NTM/LTM revenue growth is n/a

EvokAI Creative Labs's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.2M for the same period.

Over next 12 months, EvokAI Creative Labs's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate EvokAI Creative Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for EvokAI Creative Labs and other 10K+ public comps

EvokAI Creative Labs Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	n/a	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	2286%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	n/a	XXX	XXX	XXX	XXX
Opex per Employee	$0.2M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	n/a	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry